Integrative Medizin in der Gynäkologischen Onkologie – Möglichkeiten und Grenzen Teil 1

C. C. Hack; N. B. M. Hüttner; D. Paepke; P. Voiß; G. Dobos; S. Kümmel; M. Kiechle; P. A. Fasching; M. W. Beckmann

doi:10.1055/s-0034-1385131

TumorDiagnostik & Therapie, Table of Contents

TumorDiagnostik & Therapie 2014; 35(06): 337-344
DOI: 10.1055/s-0034-1385131

Thieme Onkologie aktuell

Integrative Medizin in der Gynäkologischen Onkologie – Möglichkeiten und Grenzen Teil 1

Authors

C. C. Hack

¹Universitäts-Brustzentrum Franken, Frauenklinik des Universitätsklinikums Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen – Europäische Metropolregion Nürnberg
N. B. M. Hüttner

¹Universitäts-Brustzentrum Franken, Frauenklinik des Universitätsklinikums Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen – Europäische Metropolregion Nürnberg
D. Paepke

²Frauenklinik des Klinikums rechts der Isar, Technische Universität München, München
P. Voiß

³Brustzentrum und Klinik für Senologie der Kliniken Essen-Mitte, Essen
G. Dobos

⁴Klinik für Naturheilkunde und Integrative Medizin der Kliniken Essen-Mitte, Essen
S. Kümmel

³Brustzentrum und Klinik für Senologie der Kliniken Essen-Mitte, Essen
M. Kiechle

²Frauenklinik des Klinikums rechts der Isar, Technische Universität München, München
P. A. Fasching

¹Universitäts-Brustzentrum Franken, Frauenklinik des Universitätsklinikums Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen – Europäische Metropolregion Nürnberg

⁵David Geffen School of Medicine, University of California, Los Angeles, USA
M. W. Beckmann

¹Universitäts-Brustzentrum Franken, Frauenklinik des Universitätsklinikums Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen – Europäische Metropolregion Nürnberg

Abstract

Full Text

References

Literatur für Teil 1 und Teil 2
1 Juvenal. Saturae (Iuvenalis)/Liber IV/Satura X, Vers 356.
2 Horneber MA, Bueschel G, Huber R et al. Mistletoe therapy in oncology. Cochrane Database Syst Rev 2008; (2) CD003297
3 CAHCIM. Consortion of Academic Health Centers for Integrative Medicine: about us. Im Internet: http://www.imconsortium.org/about/ Stand: 20.09.2013
4 Jonas WB, Eisenberg D, Hufford D et al. The evolution of complementary and alternative medicine (CAM) in the USA over the last 20 years. Forsch Komplementmed 2013; 20: 65-72
5 NCCAM. National Center of Complementary and Alternative Medicine: complementary, alternative and integrative health. Im Internet: http://nccam.nih.gov/health/whatiscam Stand: 20.09.2013
6 Vogler E, Brinkhaus B. Kursbuch Naturheilverfahren. 1. Aufl. München: Urban & Fischer; 2013
7 Kraft K, Stange R. Lehrbuch Naturheilverfahren. 1. Aufl. Stuttgart: Hippokrates; 2013
8 Senologie DGf. Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Germering: Zuckschwerdt; 2012
9 Hilienhof A. Deutsch, Ärzteblatt Online. Jeder zweite Europäer setzt auf Alternativmedizin (2012). In: http://www.aerzteblatt.de/nachrichten/52586/Jeder-zweite-Europaeer-setzt-auf-Alternativmedizin Stand: 20.09.2013
10 Horneber M, Bueschel G, Dennert G et al. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 2012; 11: 187-203
11 Munstedt K, Kirsch K, Milch W et al. Unconventional cancer therapy – survey of patients with gynaecological malignancy. Arch Gynecol Obstet 1996; 258: 81-88
12 Paul M, Davey B, Senf B et al. Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol 2013;
13 Langler A, Spix C, Edelhauser F et al. Use of homeopathy in pediatric oncology in Germany. Evidence-based complementary and alternative medicine. Evid Based Compement Alternat Med 2011; 2011: 867151
14 Langler A, Zuzak TJ. Complementary and alternative medicine in paediatrics in daily practice – a European perspective. Complement Ther Med 2013; 21 (Suppl. 01) 26-33
15 Tautz E, Momm F, Hasenburg A et al. Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. Eur J Cancer 2012; 48: 3133-3139
16 Fasching PA, Thiel F, Nicolaisen-Murmann K et al. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer 2007; 15: 1277-1284
17 Gerber B, Scholz C, Reimer T et al. Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 2006; 95: 199-209
18 Vapiwala N, Mick R, Hampshire MK et al. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J 2006; 12: 467-474
19 Burstein HJ, Gelber S, Guadagnoli E et al. Use of alternative medicine by women with early-stage breast cancer. New Engl J Med 1999; 340: 1733-1739
20 Weis J, Bartsch HH, Hennies F et al. Complementary medicine in cancer patients: Demand, patientsʼ attitudes and psychological beliefs. Onkologie 1998; 21: 144-149
21 Schonekaes K, Micke O, Mucke R et al. Use of complementary/alternative therapy methods by patients with breast cancer. Forsch Komplementarmed Klass Naturheilkd 2003; 10: 304-308
22 Hübner J, Münstedt K. Beratung von Patientinnen mit gynäkologischen Tumoren zur komplementären und alternativen Medizin – Gibt es einen Königsweg?. Geburtsh Frauenheilk 2013; 73: 35-37
23 Micke O, Bruns F, Glatzel M et al. Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Europ J Integrat Med 2009; 1: 22-30
24 Molassiotis A, Fernandez-Ortega P, Pud D et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol/ESMO 2005; 16: 655-663
25 Garland SN, Valentine D, Desai K et al. Complementary and alternative medicine (CAM) use and benefit finding among cancer patients. J Altern Complement Med 2013;
26 Hubner J, Muenstedt K, Muecke R et al. Counseling cancer patients on complementary and alternative medicine: background, theory, and implementation of nationwide counseling facilities. Strahlenther Onkol 2013;
27 GAÄD. Gesellschaft Anthroposophischer Ärzte in Deutschland: Die Mistel (2010). Im Internet: http://wissenschaft.mistel-therapie.de Stand: 20.09.2013
28 Steiner R, Wegmann I. Grundlegendes für eine Erweiterung der Heilkunst nach geisteswissenschaftlichen Erkenntnissen. 1. Aufl. Dornach: Rudolf Steiner; 1925
29 Hahnemann S. Organon der Heilkunst § 1. 1. Aufl. Dresden: Arnoldische Buchhandlung; 1824
30 Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog Behav Modif 1992; 28: 183-218
31 von Koerber K, Männle T, Leitzmann C. Vollwert-Ernährung. 10. Aufl. Stuttgart: Haug; 2004
32 Harper DJ. Early Chinese medical Literature: the Mawangdui medical Manuscripts. 6. Aufl. London: Kegan Paul International; 1998
33 Wikipedia. Funktionskreise auf der Zunge (TCM). In: http://de.wikipedia.org/wiki/Zungendiagnostik Stand: 20.09.2013
34 Dobos GJ, Voiss P, Schwidde I et al. Integrative oncology for breast cancer patients: introduction of an expert-based model. BMC Cancer 2012; 12: 539
35 Dobos GJ, Kirschbaum B, Choi KE. The Western model of integrative oncology: the contribution of Chinese medicine. Chin J Integr Med 2012; 18: 643-651
36 Zhang M, Liu X, Li J et al. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. Cochrane Database Syst Rev 2007; CD004921
37 Yaal-Hahoshen N, Maimon Y, Siegelmann-Danieli N et al. A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer. Oncologist 2011; 16: 1197-1202
38 Dobos G, Kümmel S. Gemeinsam gegen Krebs. 1. Aufl. München: Zabert Sandmann; 2011
39 Wikipedia. Meridiane in der Chinesischen Medizin. In: http://en.wikipedia.org/wiki/Meridian_(Chinese_medicine) Stand: 20.09.2013
40 Pomeranz B, Chiu D. Naloxone blockade of acupuncture analgesia: endorphin implicated. Life Sci 1976; 19: 1757-1762
41 Pomeranz B, Warma N. Electroacupuncture suppression of a nociceptive reflex is potentiated by two repeated electroacupuncture treatments: the first opioid effect potentiates a second non-opioid effect. Brain Res 1988; 452: 232-236
42 Deng G, Hou BL, Holodny AI et al. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med 2008; 8: 37
43 Melchart D, Weidenhammer W, Streng A et al. Prospective investigation of adverse effects of acupuncture in 97733 patients. Arch Intern Med 2004; 164: 104-105
44 He WJ, Zhao X, Li YQ et al. Adverse events following acupuncture: a systematic review of the Chinese literature for the years 1956–2010. J Altern Complement Med 2012; 18: 892-901
45 Garcia MK, McQuade J, Haddad R et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol 2013; 31: 952-960
46 Ezzo JM, Richardson MA, Vickers A et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2006; (6) CD002285
47 Gan TJ, Jiao KR, Zenn M et al. A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting. Anesth Analg 2004; 99: 1070-1075 table of contents
48 Lee A, Fan LTY. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2009; (2) CD003281
49 Walker EM, Rodriguez AI, Kohn B et al. Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 2010; 28: 634-640
50 Bokmand S, Flyger H. Acupuncture relieves menopausal discomfort in breast cancer patients: a prospective, double blinded, randomized study. Breast 2013; 22: 320-323
51 Bao T, Cai L, Giles JT et al. A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors. Breast Cancer Res Treat 2013; 138: 167-174
52 Crew KD, Capodice JL, Greenlee H et al. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol 2010; 28: 1154-1160
53 Molassiotis A, Bardy J, Finnegan-John J et al. Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol 2012; 30: 4470-4476
54 Cassileth BR, Van Zee KJ, Yeung KS et al. Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study. Cancer 2013; 119: 2455-2461
55 Franca CA, Nogueira CR, Ramalho A et al. Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy. Ann Oncol/ESMO 2011; 22: 1109-1112
56 Alhazzani W, Jacobi J, Sindi A et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2013; 41: 1555-1564
57 Smith-Warner SA, Spiegelman D, Yaun SS et al. Alcohol and breast cancer in women – A pooled analysis of cohort studies. JAMA 1998; 279: 535-540
58 Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002; 20: 1128-1143
59 DGE. Empfehlungen der deutschen Gesellschaft für Ernährung (DGE). Im Internet: http://www.dge.de/ Stand: 20.09.2013
60 Chlebowski RT, Blackburn GL, Elashoff RE et al. Dietary fat reduction in postmenopausal women with primary breast cancer: Phase III Womenʼs Intervention Nutrition Study (WINS). J Clin Oncol 2005; 23: No. 16S (Abstract)
61 Ballard-Barbash R, Hunsberger S, Alciati MH et al. Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst 2009; 101: 630-643
62 Ewertz M, Jensen MB, Gunnarsdottir KA et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 2011; 29: 25-31
63 Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med 2003; 348: 1625-1638
64 Friedenreich CM, Gregory J, Kopciuk KA et al. Prospective cohort study of lifetime physical activity and breast cancer survival. Int J Cancer 2009; 124: 1954-1962
65 Voskuil DW, van Nes JG, Junggeburt JM et al. Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients. Ann Oncol/ESMO 2010; 21: 2094-2101
66 Paul A, Lange S, Dobos G. Mind-Body Medizin im Rahmen der Integrativen Onkologie am Brustzentrum der Kliniken Essen-Mitte. Zeitschrift für Komplementärmedizin 2011; 4: 29-34
67 Dobos G, Altner N, Lange S et al. [Mind-body medicine as a part of German integrative medicine]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2006; 49: 723-728
68 Kabat-Zinn J. Full catastrophe living. How to cope with stress, pain and illness using mindfulness meditation. 15. Aufl. London: Piatkus; 2004
69 Cramer H, Lauche R, Paul A et al. Mindfulness-based stress reduction for breast cancer-a systematic review and meta-analysis. Curr Oncol 2012; 19: e343-e352
70 Zainal NZ, Booth S, Huppert FA. The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psycho-oncology 2013; 22: 1457-1465
71 Wurtzen H, Dalton SO, Elsass P et al. Mindfulness significantly reduces self-reported levels of anxiety and depression: results of a randomised controlled trial among 336 Danish women treated for stage I–III breast cancer. Eur J Cancer 2013; 49: 1365-1373
72 Andersen SR, Wurtzen H, Steding-Jessen M et al. Effect of mindfulness-based stress reduction on sleep quality: results of a randomized trial among Danish breast cancer patients. Acta Oncol 2013; 52: 336-344
73 Cramer H, Lange S, Klose P et al. Yoga for breast cancer patients and survivors: a systematic review and meta-analysis. BMC Cancer 2012; 12: 412
74 Cramer H, Lange S, Klose P et al. Can yoga improve fatigue in breast cancer patients? A systematic review. Acta Oncol 2012; 51: 559-560
75 Harder H, Parlour L, Jenkins V. Randomised controlled trials of yoga interventions for women with breast cancer: a systematic literature review. Support Care Cancer 2012; 20: 3055-3064
76 Fenlon DR, Corner JL, Haviland JS. A randomized controlled trial of relaxation training to reduce hot flashes in women with primary breast cancer. J Pain Symptom Manage 2008; 35: 397-405
77 Chan CL, Wang CW, Ho RT et al. A systematic review of the effectiveness of qigong exercise in supportive cancer care. Support Care 2012; 20: 1121-1133
78 Stan DL, Collins NM, Olsen MM et al. The evolution of mindfulness-based physical interventions in breast cancer survivors. Evidence-based complementary and alternative medicine. Evid Based Complement Alternat Med 2012; 2012: 758641
79 Lee MS, Choi TY, Ernst E. Tai chi for breast cancer patients: a systematic review. Breast Cancer Res Treat 2010; 120: 309-316
80 Montgomery GH, Bovbjerg DH, Schnur JB et al. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst 2007; 99: 1304-1312
81 Schnur JB, Bovbjerg DH, David D et al. Hypnosis decreases presurgical distress in excisional breast biopsy patients. Anesth Analg 2008; 106: 440-444
82 Montgomery GH, Kangas M, David D et al. Fatigue during breast cancer radiotherapy: an initial randomized study of cognitive-behavioral therapy plus hypnosis. Health Psychol 2009; 28: 317-322
83 Schnur JB, David D, Kangas M et al. A randomized trial of a cognitive-behavioral therapy and hypnosis intervention on positive and negative affect during breast cancer radiotherapy. J Clin Psychol 2009; 65: 443-455
84 Elkins G, Marcus J, Stearns V et al. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol 2008; 26: 5022-5026